Global Stock News

UBS in the path of NextDC (NXT ASX) share price bloodbath as financial health questions linger

UBS in the path of NextDC (NXT ASX) share price bloodbath as financial health questions linger

The bloodbath at ASX-listed data centre giant NextDC – which is facing questions about its financial health after a significant delay at a critical Melbourne asset – appears to have spread to a new casualty: UBS.

That pain dated back to September 9, when the Swiss investment banking giant was the sole arranger, lead manager and book runner on a $1.1 billion issue of convertible notes. NextDC subsequently revealed the conversion price was $16.695, or a 32 per cent premium to where shares were trading.

Loading…

Source link

Share this article

Scroll to Top